Literature DB >> 27463632

Combined branch retinal vein and artery occlusion in toxoplasmosis.

Fabio Bom Aggio1, Fernando José de Novelli1, Evandro Luis Rosa1, Mário Junqueira Nobrega1.   

Abstract

A 22-year-old man complained of low visual acuity and pain in his left eye for five days. His ophthalmological examination revealed 2+ anterior chamber reaction and a white, poorly defined retinal lesion at the proximal portion of the inferotemporal vascular arcade. There were retinal hemorrhages in the inferotemporal region extending to the retinal periphery. In addition, venous dilation, increased tortuosity, and ischemic retinal whitening along the inferotemporal vascular arcade were also observed. A proper systemic work-up was performed, and the patient was diagnosed with ocular toxoplasmosis. He was treated with an anti-toxoplasma medication, and his condition slowly improved. Inferior macular inner and middle retinal atrophy could be observed on optical coherence tomography as a sequela of ischemic injury. To our knowledge, this is the first report of combined retinal branch vein and artery occlusion in toxoplasmosis resulting in a striking and unusual macular appearance.

Entities:  

Mesh:

Year:  2016        PMID: 27463632     DOI: 10.5935/0004-2749.20160054

Source DB:  PubMed          Journal:  Arq Bras Oftalmol        ISSN: 0004-2749            Impact factor:   0.872


  3 in total

1.  Ruptured Retinal Arterial Macroaneurysm Secondary to Toxoplasmic Kyrieleis Arteriolitis: A Case Report.

Authors:  Natalie Huang; W Andrew Lee; Sean Rivera; Sandra R Montezuma
Journal:  Case Rep Ophthalmol       Date:  2017-07-24

2.  Optical coherence tomography angiography findings in macular toxoplasma retinochoroiditis: A case report.

Authors:  Alejandro L Perez; Rosa A Lozada; Andres Emanuelli; Armando L Oliver
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-02

Review 3.  Combined retinal vascular occlusion: Demography, clinical features, visual outcome, systemic co-morbidities, and literature review.

Authors:  Vishal Raval; Sameera Nayak; Merlin Saldanha; Subhadra Jalali; Rajeev Reddy Pappuru; Raja Narayanan; Taraprasad Das
Journal:  Indian J Ophthalmol       Date:  2020-10       Impact factor: 1.848

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.